REVELATION BIOSCIENCES, INC

Profile

Company Names

REVELATION BIOSCIENCES, INC
REVELATION THERAPEUTICS, LLC

Addresses

4660 LAJOLLA VILLAGE DRIVE, SUITE 100, SAN DIEGO, CA 92122

350 SHARON PARK DRIVE, R4, MENLO PARK, CA 94025

Phone Numbers

650-800-3717
650-272-7018

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$10,498,850.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2021-01-29 
$4,353,102.00 
$4,353,102.00 
$0.00 
Equity 
2
2021-01-04 
$5,144,458.00 
$5,144,458.00 
$0.00 
Equity 
1
2020-05-11 
$1,001,290.00 
$1,001,290.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JENNIFER 
 
CARVER 
DIRECTOR
QUANDL INC.   |  REVELATION BIOSCIENCES, INC
CURT 
 
LABELLE 
DIRECTOR
SAFEOP SURGICAL, INC.   |  EXAGEN DIAGNOSTICS INC   |  KUROBE PHARMACEUTICALS, INC.   |  EYENOVIA, INC.   |  INPRESS TECHNOLOGIES, INC.   |  REVELATION BIOSCIENCES, INC   |  OPHIREX, INC.   |  CXL OPHTHALMICS, INC.   |  VEDANTA BIOSCIENCES, INC.   |  RESOLUTE RESOURCES LTD./CAN   |  NOVOCUFF, INC.
JAMES 
M. 
ROLKE 
DIRECTOR, EXECUTIVE OFFICER
REVELATION THERAPEUTICS, LLC   |  REVELATION BIOSCIENCES, INC
JESS 
 
ROPER 
DIRECTOR
DEXCOM INC   |  BIOLASE, INC   |  REVELATION BIOSCIENCES, INC
GEORGE 
F. 
TIDMARSH 
DIRECTOR
HORIZON THERAPEUTICS INC   |  REVELATION THERAPEUTICS, LLC   |  REVELATION BIOSCIENCES, INC
CHESTER 
S. 
ZYGMONT 
EXECUTIVE OFFICER, DIRECTOR
REVELATION THERAPEUTICS, LLC   |  REVELATION BIOSCIENCES, INC
CHESTER 
S. 
ZYGMONT III 
EXECUTIVE OFFICER
REVELATION BIOSCIENCES, INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-05-04
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-01-04 
2021-04-23
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-01-29 
2021-04-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-01-29 
2020-07-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-05-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NATIONAL SECURITIES CORPORATION
7539